Chinese General Practice ›› 2025, Vol. 28 ›› Issue (27): 3399-3409.DOI: 10.12114/j.issn.1007-9572.2024.0424
• Original Research • Previous Articles Next Articles
Received:
2024-11-10
Revised:
2025-03-20
Published:
2025-09-20
Online:
2025-07-22
Contact:
ZHANG Ye
通讯作者:
张野
作者简介:
作者贡献:
张红石进行研究的构思与设计及可行性分析、设计研究方案,后期数据收集整理、统计分析并撰写论文;曲子涵、孙雪峰参与设计研究方案,进行动物造模、实验干预、数据收集整理及统计分析;王宇峰进行论文及英文的修订;丛德毓、张野负责文章的质量控制及审校,对文章整理负责,监督管理。
基金资助:
Add to citation manager EndNote|Ris|BibTeX
URL: https://www.chinagp.net/EN/10.12114/j.issn.1007-9572.2024.0424
组别 | 只数 | 潜睡眠时间 | 睡眠持续时间 |
---|---|---|---|
空白组 | 6 | 5.70±1.64 | 36.30±7.26 |
模型组 | 6 | 10.60±3.53a | 24.50±7.01a |
治疗组 | 6 | 11.00±3.59a | 26.00±6.27a |
F值 | 12.21 | 10.01 | |
P值 | <0.001 | <0.001 |
Table 1 Test results of sodium pentobarbital after molding
组别 | 只数 | 潜睡眠时间 | 睡眠持续时间 |
---|---|---|---|
空白组 | 6 | 5.70±1.64 | 36.30±7.26 |
模型组 | 6 | 10.60±3.53a | 24.50±7.01a |
治疗组 | 6 | 11.00±3.59a | 26.00±6.27a |
F值 | 12.21 | 10.01 | |
P值 | <0.001 | <0.001 |
分组 | 只数 | 自发举爪次数(次) | 寻找平台时间(min) | 体质量(g) |
---|---|---|---|---|
空白组 | 6 | 3.90±2.88 | 50.26±16.79 | 219.10±5.32 |
模型组 | 6 | 7.30±3.53a | 88.15±23.33a | 198.60±7.04a |
治疗组 | 6 | 3.80±2.20b | 54.66±24.63b | 209.40±11.50b |
F值 | 8.08 | 5.36 | 21.18 | |
P值 | 0.002 | 0.005 | <0.001 |
Table 2 Results of behavioral test and weight change of rats in each group after treatment
分组 | 只数 | 自发举爪次数(次) | 寻找平台时间(min) | 体质量(g) |
---|---|---|---|---|
空白组 | 6 | 3.90±2.88 | 50.26±16.79 | 219.10±5.32 |
模型组 | 6 | 7.30±3.53a | 88.15±23.33a | 198.60±7.04a |
治疗组 | 6 | 3.80±2.20b | 54.66±24.63b | 209.40±11.50b |
F值 | 8.08 | 5.36 | 21.18 | |
P值 | 0.002 | 0.005 | <0.001 |
蛋白ID | 蛋白描述 | 基因名 | 模型组/空白组比值 | 模型组/空白组P值 | 变化趋势 |
---|---|---|---|---|---|
P01237 | Prolactin | Prl | 302.515 2 | 6.265 | 上调 |
P01244 | Somatotropin | Gh1 | 51.151 8 | 2.612 | 上调 |
A0A0H2UHJ1 | Calgranulin-B | S100a9 | 14.092 7 | 0.006 | 上调 |
P97887 | Presenilin-1 | Psen1 | 14.987 1 | 2.687 | 上调 |
A0A0G2JSP8 | Creatine kinase | Ckm | 4.700 2 | 4.123 | 上调 |
F1M0N1 | Tyrosine-protein kinase | Abl2 | 6.059 9 | 3.627 | 上调 |
A0A0G2K2Z0 | EMAP-like 4 | Eml4 | 3.797 8 | 4.866 | 上调 |
Q9Z1J7 | Amino acid transporter | Slc1a5 | 5.513 9 | 0.026 | 上调 |
P06866 | Haptoglobin | Hp | 3.908 9 | 9.049 | 上调 |
Q5PPI1 | Serine/arginine-rich splicing factor 9 | Srsf9 | 2.804 1 | 0.014 | 上调 |
G3V8M1 | DNA polymerase | Pold1 | 4.500 1 | 0.005 | 上调 |
P19969 | Gamma-aminobutyric acid receptor subunit alpha-5 | Gabra5 | 0.369 3 | 3.140 | 下调 |
Q331S7 | Dysbindin domain-containing 2 | Dbndd2 | 0.460 5 | 0.001 | 下调 |
A0A0G2K2P3 | TNF alpha-induced protein 8 | Tnfaip8 | 0.532 6 | 0.003 | 下调 |
Q99P99 | Histone deacetylase 4 | Hdac4 | 0.265 2 | 4.219 | 下调 |
F1M702 | Cadherin 18 | Cdh18 | 0.341 0 | 0.001 | 下调 |
O70196 | Prolyl endopeptidase | Prep | 0.535 7 | 9.921 | 下调 |
Table 3 Differences in expression of differential proteins in hypothalamus of insomnia rats before and after modeling in model group and blank group
蛋白ID | 蛋白描述 | 基因名 | 模型组/空白组比值 | 模型组/空白组P值 | 变化趋势 |
---|---|---|---|---|---|
P01237 | Prolactin | Prl | 302.515 2 | 6.265 | 上调 |
P01244 | Somatotropin | Gh1 | 51.151 8 | 2.612 | 上调 |
A0A0H2UHJ1 | Calgranulin-B | S100a9 | 14.092 7 | 0.006 | 上调 |
P97887 | Presenilin-1 | Psen1 | 14.987 1 | 2.687 | 上调 |
A0A0G2JSP8 | Creatine kinase | Ckm | 4.700 2 | 4.123 | 上调 |
F1M0N1 | Tyrosine-protein kinase | Abl2 | 6.059 9 | 3.627 | 上调 |
A0A0G2K2Z0 | EMAP-like 4 | Eml4 | 3.797 8 | 4.866 | 上调 |
Q9Z1J7 | Amino acid transporter | Slc1a5 | 5.513 9 | 0.026 | 上调 |
P06866 | Haptoglobin | Hp | 3.908 9 | 9.049 | 上调 |
Q5PPI1 | Serine/arginine-rich splicing factor 9 | Srsf9 | 2.804 1 | 0.014 | 上调 |
G3V8M1 | DNA polymerase | Pold1 | 4.500 1 | 0.005 | 上调 |
P19969 | Gamma-aminobutyric acid receptor subunit alpha-5 | Gabra5 | 0.369 3 | 3.140 | 下调 |
Q331S7 | Dysbindin domain-containing 2 | Dbndd2 | 0.460 5 | 0.001 | 下调 |
A0A0G2K2P3 | TNF alpha-induced protein 8 | Tnfaip8 | 0.532 6 | 0.003 | 下调 |
Q99P99 | Histone deacetylase 4 | Hdac4 | 0.265 2 | 4.219 | 下调 |
F1M702 | Cadherin 18 | Cdh18 | 0.341 0 | 0.001 | 下调 |
O70196 | Prolyl endopeptidase | Prep | 0.535 7 | 9.921 | 下调 |
蛋白ID | 蛋白描述 | 基因名 | 治疗组/模型组比值 | 治疗组/模型组P值 | 变化趋势 |
---|---|---|---|---|---|
P19969 | Gamma-aminobutyric acid receptor subunit alpha-5 | Gabra5 | 4.058 0 | 3.899 | 上调 |
B2GV05 | RNA-binding protein 5 | Rbm5 | 1.948 7 | 0.038 | 上调 |
Q63754 | Beta-synuclein | Sncb | 3.237 1 | 0.018 | 上调 |
Q497A2 | D-serine modulator-1 | Slc35b2 | 2.211 8 | 0.026 | 上调 |
F1M702 | Cadherin 18 | Cdh18 | 2.277 9 | 0.002 | 上调 |
Q03344 | ATPase inhibitor,mitochondrial | Atp5if1 | 2.525 2 | 0.008 | 上调 |
Q99P99 | Histone deacetylase 4 | Hdac4 | 2.761 0 | 1.328 | 上调 |
A0A0G2JSP8 | Creatine kinase | Ckm | 0.258 3 | 1.725 | 下调 |
P97887 | Presenilin-1 | Psen1 | 0.317 8 | 0.014 | 下调 |
Q9WVH8 | Fibulin-5 | Fbln5 | 0.224 0 | 0.001 | 下调 |
Table 4 Differences in hypothalamic differential protein expression of insomnia rats before and after treatment in treatment group and model group
蛋白ID | 蛋白描述 | 基因名 | 治疗组/模型组比值 | 治疗组/模型组P值 | 变化趋势 |
---|---|---|---|---|---|
P19969 | Gamma-aminobutyric acid receptor subunit alpha-5 | Gabra5 | 4.058 0 | 3.899 | 上调 |
B2GV05 | RNA-binding protein 5 | Rbm5 | 1.948 7 | 0.038 | 上调 |
Q63754 | Beta-synuclein | Sncb | 3.237 1 | 0.018 | 上调 |
Q497A2 | D-serine modulator-1 | Slc35b2 | 2.211 8 | 0.026 | 上调 |
F1M702 | Cadherin 18 | Cdh18 | 2.277 9 | 0.002 | 上调 |
Q03344 | ATPase inhibitor,mitochondrial | Atp5if1 | 2.525 2 | 0.008 | 上调 |
Q99P99 | Histone deacetylase 4 | Hdac4 | 2.761 0 | 1.328 | 上调 |
A0A0G2JSP8 | Creatine kinase | Ckm | 0.258 3 | 1.725 | 下调 |
P97887 | Presenilin-1 | Psen1 | 0.317 8 | 0.014 | 下调 |
Q9WVH8 | Fibulin-5 | Fbln5 | 0.224 0 | 0.001 | 下调 |
组别 | 只数 | Psen1 | Ckm | Gabra5 | Hdac4 |
---|---|---|---|---|---|
空白组 | 6 | 0.14±0.01 | 0.51±0.14 | 1.31±0.16 | 1.75±0.12 |
模型组 | 6 | 2.10±0.10a | 2.38±0.11a | 0.48±0.07a | 0.47±0.10a |
治疗组 | 6 | 0.11±0.02b | 0.61±0.24b | 1.96±0.16b | 1.28±0.11b |
F值 | 985.40 | 222.70 | 175.70 | 260.80 | |
P值 | <0.001 | <0.001 | <0.001 | <0.001 |
Table 5 Determination of protein expression levels of Psen1,Ckm,Gabra5 and Hdac4
组别 | 只数 | Psen1 | Ckm | Gabra5 | Hdac4 |
---|---|---|---|---|---|
空白组 | 6 | 0.14±0.01 | 0.51±0.14 | 1.31±0.16 | 1.75±0.12 |
模型组 | 6 | 2.10±0.10a | 2.38±0.11a | 0.48±0.07a | 0.47±0.10a |
治疗组 | 6 | 0.11±0.02b | 0.61±0.24b | 1.96±0.16b | 1.28±0.11b |
F值 | 985.40 | 222.70 | 175.70 | 260.80 | |
P值 | <0.001 | <0.001 | <0.001 | <0.001 |
分组 | 只数 | Psen1 | Ckm | Gabra5 | Hdac4 |
---|---|---|---|---|---|
空白组 | 6 | 260.1±78.8 | 551.7±64.1 | 227.7±21.5 | 206.7±25.7 |
模型组 | 6 | 528.4±106.0a | 637.6±30.3a | 158.0±21.0a | 468.1±47.5a |
治疗组 | 6 | 296.5±73.3b | 558.8±19.9b | 199.0±22.9b | 178.3±9.2b |
F值 | 8.32 | 7.77 | 7.79 | 76.36 | |
P值 | 0.019 | 0.021 | 0.022 | <0.001 |
Table 6 Protein expression levels of Psen1,Ckm,Gabra5 and Hdac4 of 3 groups of rats
分组 | 只数 | Psen1 | Ckm | Gabra5 | Hdac4 |
---|---|---|---|---|---|
空白组 | 6 | 260.1±78.8 | 551.7±64.1 | 227.7±21.5 | 206.7±25.7 |
模型组 | 6 | 528.4±106.0a | 637.6±30.3a | 158.0±21.0a | 468.1±47.5a |
治疗组 | 6 | 296.5±73.3b | 558.8±19.9b | 199.0±22.9b | 178.3±9.2b |
F值 | 8.32 | 7.77 | 7.79 | 76.36 | |
P值 | 0.019 | 0.021 | 0.022 | <0.001 |
[1] |
|
[2] |
|
[3] |
|
[4] |
|
[5] |
|
[6] |
张红石. 基于"脑-肠互动"下的腹部推拿对心脾两虚型PI的fMRI及BGP影响的研究[D]. 长春:长春中医药大学,2020.
|
[7] |
范英兰,张宏,甘雨,等. 抗失眠中药复方对KM小鼠戊巴比妥钠催眠作用影响随机平行对照研究[J]. 实用中医内科杂志,2016,30(9):90-94. DOI:10.13729/j.issn.1671-7813.2016.09.34.
|
[8] |
郅晓宇. 振腹环揉法治疗心脾两虚型慢性失眠的过度觉醒机制研究[D]. 长春:长春中医药大学,2023.
|
[9] |
严开伟,杨洁,梁繁荣. 浅议中医"和胃安神"疗法与失眠的关系[J]. 辽宁中医杂志,2016,43(11):2289-2292. DOI:10.13192/j.issn.1000-1719.2016.11.018.
|
[10] |
张野. 基于脑肠互动理论探讨振腹环揉法介导CRH/CRHR1通路治疗失眠的代谢机制研究[D]. 长春:长春中医药大学,2022.
|
[11] | |
[12] |
|
[13] |
张竞天. PS1、PSAP和DR6的相互联系促进细胞凋亡的机制研究[D]. 长春:吉林大学,2020.
|
[14] |
周多奇,龚莉,钱振宇. 肌酸激酶的生理功能与运动[J]. 安庆师范学院学报(自然科学版),2016,22(3):113-118. DOI:10.13757/j.cnki.cn34-1150/n.2016.03.029.
|
[15] |
周艳丽,高希言,王培育,等.针刺不同腧穴对失眠大鼠下丘脑γ-氨基丁酸和γ-氨基丁酸A受体的影响[J].针刺研究,2012,37(4):302-307.DOI:10.13702/j.1000-0607.2012.04.010.
|
[16] |
|
[17] |
|
[18] |
|
[19] |
林炳岐,李峰,马捷,等. 基于GABA能系统通路探讨失眠的机制[J]. 现代生物医学进展,2018,18(3):565-568. DOI:10.13241/j.cnki.pmb.2018.03.037.
|
[20] |
曾雪爱,黄俊山,周春权,等. 松郁安神方对失眠大鼠脑组织氨基酸类神经递质的影响[J]. 福建医药杂志,2015,37(5):1-3,23. DOI:10.20148/j.fmj.2015.05.001.
|
[21] |
胡沿每,刘子重,郭美娜,等.早老素Ps1突变基因对阿尔茨海默病模型鼠表观有效性的影响[J].中国药理学通报,2020,36(8):1076-1083. DOI:10.3969/i.issn.1001-1978.2020.08.009.
|
[22] |
解俊樊. 神经肽S及受体系统抗焦虑样行为与睡眠的作用和机制[D]. 兰州:兰州大学,2017.
|
[23] |
|
[24] |
单贝贝,李娜,刘佳玮,等. 基于网络药理学及分子对接技术探讨四逆散"异病同治"失眠和功能性胃肠病的共同作用机制[J/OL]. 环球中医药,2024:1-11.[2024-05-28].
|
[25] |
|
[1] | Chinese Academy Society of Sleep Medicine, Chinese Medical Doctor Association, Sleep Medicine Group, China Neurologist Association. Chinese Guideline for Diagnosis and Treatment of Co-morbid Insomnia and Obstructive Sleep Apnea (2024) [J]. Chinese General Practice, 2025, 28(11): 1289-1303. |
[2] | YU Yuemin, MO Feifei, LI Lesi, PAN Jiyang. The Assessment Tools and Influencing Factors of Insomnia in Chinese Adolescents: a Scoping Review [J]. Chinese General Practice, 2025, 28(10): 1213-1219. |
[3] | GUO Yumeng, CUI Yanglin, ZHANG Xianzhong. Based on Mendelian Randomization to Explore the Causal Relationship with Insomnia and Gut Microbiota [J]. Chinese General Practice, 2025, 28(08): 954-961. |
[4] | GUO Jia, CAO Chunmei, LIU Guochun, ZHENG Man, ZHU Ruihan, LONG Wei. Effects of Different Exercise Types on Sleep in Insomnia Patients: a Network Meta-analysis [J]. Chinese General Practice, 2024, 27(35): 4376-4387. |
[5] | CHEN Pengfei, LIU Yaxi, WANG Tuzhi, ZHANG Guimei, CAI Yixian, PAN Jiyang. The Effect of E-aid Brief Behavioral Therapy for Insomnia on Insomnia Disorders [J]. Chinese General Practice, 2024, 27(35): 4370-4375. |
[6] | DONG Menglong, LIN Zhifeng, FAN Mengmeng, XUE Shengwen, LIU Yuhang, WANG Yi, CHENG Jinxiang. Advance in Evaluation of the Clinical Efficacy of Non-benzodiazepine Drugs in Treating Comorbid Insomnia and Sleep Apnea [J]. Chinese General Practice, 2024, 27(35): 4388-4396. |
[7] | China Sleep Research Society. Expert Consensus on Digital Therapies for Insomnia in China [J]. Chinese General Practice, 2024, 27(04): 381-390. |
[8] | WU Zixing, HU Xin, TAO Shimeng, HE Youjun, CAI Chuanyun, JIANG Wei. Correlations of Cognitive Function with Insomnia Severity, Serum Levels of 25-hydroxy Vitamin D3 and Tumor Necrosis Factor-α in Elderly Patients with Chronic Insomnia [J]. Chinese General Practice, 2024, 27(03): 328-334. |
[9] | HE Jingyi, WANG Fang, SHUI Xiaoling, LI Ling, LIANG Qian. Efficacy of Non-pharmacological Interventions to Improve Perimenopausal Insomnia Symptoms: a Network Meta-analysis [J]. Chinese General Practice, 2023, 26(31): 3963-3974. |
[10] | ZHU Lin, GUO Yankui, GAO Chen, CHEN Xuezhi, WANG Fashuai. Efficacy of Western Medicine, Chinese Patent Medicine and Their Combination on Post-stroke Insomnia: a Network Meta-analysis [J]. Chinese General Practice, 2023, 26(30): 3823-3832. |
[11] | Climacteric Health Care Branch of Chinese Preventive Medicine Association, Gynecologic Endocrinology and Fertility Professional Committees of China Association for Promotion of Health Science and Technology, Professional Committees of Beijing Association of the Integrating of Traditional and Western Medicine. Chinese Expert Consensus on Clinical Management of Menopause-related Insomnia [J]. Chinese General Practice, 2023, 26(24): 2951-2958. |
[12] | CHEN Pinqi, ZHANG Liqing, XIANG Ting, SUN Xizhe, PAN Jiyang. Advances in the Use of Regional Homogeneity from Resting-state Functional MRI for the Diagnosis of Insomnia in Depressive Disorder [J]. Chinese General Practice, 2022, 25(35): 4462-4467. |
[13] | PAN Jiyang, FANG Yiru, HU Shaohua, LU Zheng, SU Changjun, TANG Xiangdong, WANG Tao, WANG Wenqiang, YAO Zhijian, YUAN Yonggui, YU Huan, ZHAN Shuqin, ZHAO Zhongxin, ZHANG Xulai, ZHANG Ling, LI Lingjiang. Expert Recommendations for Clinical Application of Trazodone Hydrochloride Sustained Release [J]. Chinese General Practice, 2022, 25(33): 4099-4105. |
[14] | Longlin YE, Yeqing WANG, Pingping JIANG, Yingxun LIN, Min HONG. Clinical, Interleukin-6 and Tumor Necrosis Factor-α Responses to Needling Posterior Neck Meridian Sinews Nodes and Herbal Ointment Externally Applied to Yongquan Acupoint in Patients with Post-ischemic Stroke Insomnia [J]. Chinese General Practice, 2022, 25(27): 3422-3428. |
[15] | Jinxiang CHENG, Liping ZHANG, Changjun SU. Update on the Withdrawal from Long-term Use of Benzodiazepines in Patients with Chronic Insomnia Disorder [J]. Chinese General Practice, 2022, 25(27): 3347-3351. |
Viewed | ||||||
Full text |
|
|||||
Abstract |
|
|||||